Expanding Capabilities to Support Early and Late-Stage Drug Development with Comprehensive Manufacturing SolutionsElkridge, Maryland--(Newsfile ...

Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

Broadening global laboratory services for clinical research To serve pharma and biotech customers with advanced laboratory services and leading-edge instrumentation across all phases of pharmaceutical ...

Researchers describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease ...